Sort
39,280 grants matching “leukemia”
Mitochondrial Maintenance Mechanisms of Stem Cells and Aging
$388,723Hans-Willem E Snoeck · Columbia University Health Sciences · R01 · FY2021 · AG
Mitochondrial Maintenance Mechanisms of Stem Cells and Aging
$388,723Hans-Willem E Snoeck · Columbia University Health Sciences · R01 · FY2019 · AG
Regulation of Embryonic Erythropoiesis by BMP Signaling
$388,693Todd R Evans · Weill Medical Coll Of Cornell Univ · R37 · FY2014 · HL
Heat Shock Transcription Factor 1 Specifically Regulates AML Stem Cell Self-Renewal
$388,690Chen Zhao · Case Western Reserve University · R01 · FY2023 · CA
MEMBRANES AND SIGNAL TRANSDUCTION
$388,673Salk Institute For Biological Studies · R01 · FY2000 · CA
T cell repertoire of graft-versus-host disease and graft-versus-tumor effects
$388,635Thea Friedman · Hackensack University Medical Center · R01 · FY2011 · CA
T cell repertoire of graft-versus-host disease and graft-versus-tumor effects
$388,635Robert Korngold · Hackensack University Medical Center · R01 · FY2012 · CA
APPLYING ERROR-CORRECTED SEQUENCING TO DETECT MINIMAL RESIDUAL IN THE AAML 1031 STUDY
$388,615Todd E Druley · Washington University · R01 · FY2017 · CA
Aberrant hematopoiesis: E proteins and AML1-ETO in leukemogenesis
$388,575Jinsong Zhang · University Of Cincinnati · R01 · FY2012 · HL
Histone deacetylase 7 and its interacting proteins in endothelial cells
$388,575Hung-Ying Kao · Case Western Reserve University · R01 · FY2012 · HL
Role of JAK2V617F in the Pathogenesis of Myeloproliferative Disorders.
$388,575Golam Mohi · Upstate Medical University · R01 · FY2012 · HL
Project 1: Tumor Microenvironment Initiators of the Metastatic Cascade in High-Risk Prostate Cancer
$388,567Joshua Michael Lang · University Of Wisconsin-Madison · P50 · FY2023 · CA
Identifying host factors that block engraftment and progression of transmissible cancer as a model of AML
$388,546Michael Jeffrey Metzger · Pacific Northwest Research Institute · R01 · FY2024 · CA
ARID5B and disparities of childhood leukemia
$388,534Jun J. Yang · St. Jude Children'S Research Hospital · U01 · FY2014 · CA
SENIOR LEADERS
$388,533Max S. Wicha · University Of Michigan At Ann Arbor · P30 · FY2009 · CA
Elucidating the Function of PKC-theta in Alloreactivity and GVHD
$388,526Amer Aziz Beg · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2013 · AI
Novel mechanisms of immune activation following allogeneic, hematopoietic stem ce
$388,325John James Letterio · Case Western Reserve University · R01 · FY2014 · HL
Investigations of Consequences of U2AF1 Mutations in MDS
$388,325Jaroslaw P Maciejewski · Cleveland Clinic Lerner Com-Cwru · R01 · FY2014 · HL
Novel Approaches for Antitumor and Antiviral Agents
$388,323Barry M Trost · Stanford University · R01 · FY2014 · GM
JAK-STAT signaling during CNS development
$388,289Yi Eve Sun · University Of California Los Angeles · R01 · FY2007 · MH
Reprogramming myeloid cells to inhibit cancer development
$388,283Chengcheng Zhang · Ut Southwestern Medical Center · R01 · FY2022 · CA
Monokine Gene Expression/Regulation in Lung Injury
$388,230Steven Lynn Kunkel · University Of Michigan At Ann Arbor · R01 · FY2015 · HL
Targeting Microenvironmental Signals in Myeloid Malignancies
$388,221Jeevisha Bajaj · University Of Rochester · R01 · FY2024 · CA
BCR/ABL SIGNALING IN HUMAN LEUKEMIAS
$388,127Duke University · R01 · FY2002 · CA
Targeted aberrant signaling in CBL-mutant leukemia
$388,111Benjamin Levine Ebert · Dana-Farber Cancer Inst · P01 · FY2021 · CA